MAPK3 and colorectal carcinoma: Analysis of signaling-activated downstream spiperone treatment showed the activation of ERK1/2 and P38 MAPK pathways in both HCT116 and CRC-SC#1 cells (Supplementary Figure S12b–e); therefore, we investigated their role in cell death by using specific inhibitors.